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AIRWAY irritation effects after single and repeated
inhalation exposures to aerosols of b-glucan (grifo-
lan) were investigated in mice. In addition, the effects
on serum total immunoglobulin E (IgE) production
and histopathological inflammation in the respira-
tory tract were studied. The b-glucan aerosols pro-
voked slight sensory irritation in the airways, but the
response was not concentration dependent at the
levels studied. Slight pulmonary irritation was ob-
served after repeated exposures. No effect was found
on the serum total IgE levels, and no signs of
inflammation were seen in the airways 6 h after the
final exposure. The results suggest that, irrespective
of previous fungal sensitization of the animals,
inhaled b-glucan may cause symptoms of respiratory
tract irritation but without apparent inflammation.
Respiratory tract irritation reported after inhalation
of fungi may not be entirely attributed to b-glucan.
Key words: Fungal cell-wall component, Grifolan, Inhala-
tion exposure, Mice
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Introduction
Occupants in buildings with moisture or mold
damage often complain of eye and upper respiratory
tract irritation. Based on epidemiological studies,
fungi (molds) have been suggested to be responsible
for many of the irritative symptoms. Fungi contain
several specific agents such as microbially produced
volatile organic compounds, mycotoxins, and the
polyglucose cell-wall component (10/3)-b-D-
glucan.
1 4 Airborne b-glucan levels in indoor air
have been used as indicators of total fungal cell mass
and related to symptoms of irritation, cough, tired-
ness and headache.
5,6 Using the pure substance, a
slightly increased prevalence of throat irritation and
cough has been demonstrated in healthy, non-
sensitive persons after a 4 h inhalation exposure to
b-glucan at 210 ng/m
3.
7
The sensation of irritation experienced by persons
exposed to molds or to other agents in their homes
may originate either from an inflammatory reaction in
the tissue or from a direct stimulation of the nerve
endings; the two processes do not have to be related.
A standardized mouse bioassay [American Society for
Testing and Materials (ASTM)
8] is used to assess the
latter by determining changes in the breathing
pattern of mice during inhalation of aerosols, gases
or vapors. Thus, effects on various parts of the
respiratory system (i.e. upper and lower respiratory
tract and conducting airways) can be recorded. With
the head-out body plethysmography, we have pre-
viously shown that inhalation of Stachybotrys char-
tarum extract aerosols that contained b-glucan
provoked sensory irritation in the airways of mice,
whereas aerosols of ovalbumin or phosphate-buf-
fered saline (PBS) did not cause this effect.
9
In view of this, we undertook experiments to
investigate the potency of b-glucan to cause upper
respiratory tract irritation and inflammation. Mice
were exposed to an aerosol of b-glucan at different
concentrations, and the effects on the respiratory
pattern were recorded. Furthermore, the reaction in
mice pre-exposed to a fungal extract was evaluated
during repeated exposures to b-glucan.
Research Communication
ISSN 0962-9351 print/ISSN 1466-1861 online/03/030139-08 – 2003 Taylor & Francis Ltd
DOI: 10.1080/0962935031000134851
139Materials and methods
Animals
A total of 30 female, 6-week-old (13 weeks old at the
end) BALB/cJBom mice (M&B A/S, Ry, Denmark)
and 24 male 5-week-old Ico:OF1 mice (IOPS Caw;
Iffa Credo, Saint-Germain sur L’Arbresle, France)
were used in the experiments (Table 1). To study
the potency of b-glucan to provoke sensory irritation,
the OF1 strain was used as this strain has been widely
used in the ASTM method.
10 For another purpose (i.e.
to illustrate immunological changes due to repeated
exposures in mice pre-sensitized to a fungal extract),
we chose the BALB/c mice. The animals were housed
in a carefully controlled environment in an animal
room that operated on a 12-h dark/light cycle at
19.5 /20.58C and at 60 /65% relative humidity.
Groups of four mice were housed in stainless steel
cages (42 cm deep /24 cm wide /13 cm high)
bedded with non-autoclaved cellulose wadding (Ka-
trin Care Wadding; Metsa ¨ Tissue, Ma ¨ntta ¨, Finland).
Food (Labfor R36; Lactamin AB, Stockholm, Sweden)
and tap water were provided to the animals ad
libitum.
Immunization of mice with a fungal extract
For fungal immunizations of two mouse groups
(groups Sc and Sc/glu), the fungal extract was
prepared from a non-toxic strain of S. chartarum
(Sc) (American Type Culture Collection 208877,
previously stored as University of Kuopio strain 10)
according to Korpi et al.
9 This extract has been
shown to contain b-glucan, endotoxin and ergosterol
for 6.7 ng/ml, 0.02 ng/ml, and 6.4 mg/ml, respec-
tively.
9 These concentrations were determined per
milliliter of the dialyzed and sterile-filtered solution
before lyophilization.
Mice were either immunized intraperitoneally with
50 mg S. chartarum extract in adjuvant twice with a 2-
week interval, or treated with equal amount of PBS
(200 ml), or not injected at all (see Table 1).
Commercial Imject Alum (Pierce, Rockford, IL, USA)
was used as an adjuvant according to the manufac-
turer’s instructions. The experiments were performed
in agreement with the European Convention for the
Protection of Vertebrate Animals used for Experi-
mental and Other Scientific Purposes (Strasbourg, 18
March 1986, adopted in Finland 31 May 1990). The
study was approved by the Animal Care and Use
Committee of the University of Kuopio, and by the
provincial government.
Generation of glucan aerosols
We used one of the available forms of fungal b-
glucans, grifolan, which is a gel-forming 1,6-
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140 Mediators of Inflammation Vol 12  2003branched (10/3)-b-D-glucan isolated from liquid-
cultured mycelium of Grifola frondosa (kindly pro-
vided by Prof. Ohno, Tokyo University of Pharmacy
and Life Science, Tokyo, Japan). A water-soluble form
of b-glucan was chosen because the S. chartarum
extract studied earlier (with its b-glucan moiety) was
readily soluble in water and PBS. The resulting
grifolan has been analyzed to contain 91% sugar
(glucose as a component sugar) and 0.3% pro-
tein.
11,12 Two b-glucan batches were used in this
experiment. At first, the glucan was dissolved in 0.5 N
NaOH to give 0.5% (w/v) solution, and the con-
secutive working solutions were diluted in sterile
water (Medipolar, Oulu, Finland). From the glucan
solution (or from sterile water), polydisperse aerosols
were generated with an atomizer as described pre-
viously.
9 For safety precautions, all the exposure
apparatuses were held in a safety hood and the
exhaust air was filtered prior to leading it into exhaust
air duct.
To determine the glucan concentration of aerosols
in the exposure chamber and to ascertain absence of
bacterial contamination by determining endotoxin
concentration, air samples (2 l/min) were collected at
the outlet of the exposure chamber on a polycarbo-
nate filter (ATTP03700, 0.8 mm, 37 mm; Millipore,
Molsheim, France). The b-glucan and endotoxin
concentrations were determined from a selection of
the filters using specific Limulus lysates.
13 A side-
stream from the outlet of the chamber was led via a
dilutor to the optical particle counter (Hiac/Royco
model 5000; Pacific Scientific, Silver Springs, MD,
USA) to register the number and size distribution of
the generated aerosols continuously during the
experiments. This device separates particles into six
different classes: from 0.3 to 0.5 mm, from 0.5 to 1.0
mm, from 1.0 to 3.0 mm, from 3.0 to 5.0 mm, from 5.0
to 10 mm, and particles over 10 mm. This generator
produces also particlesB/0.3 mm.
9
Exposure and mouse bioassay
The six groups of naı ¨ve/glu mice were each exposed
once to different glucan concentrations (from 37 to
1189 mg/m
3) or to sterile water (control experiment)
(Table 1). In the immunized mice, the first aerosol
exposure to glucan was performed 12 days after the
second immunization of the PBS/glu and Sc/glu
mice. The immunized mice were exposed to glucan
aerosol on days 0, 1, 7, 8, 14, 15, and 21 (Table 1).
Before each aerosol exposure, there was initially a
15 min acclimation period followed by a 15 min
control (baseline) period when baseline respiratory
parameter values were obtained for each mouse. The
exposures lasted for 15 /20 min and were followed
by a 15 min recovery period. During the acclimatiza-
tion, control and recovery periods, filtered com-
pressed air was fed into the exposure chamber.
The mouse bioassay followed the ASTM E 981-84
standard,
8 as described by Korpi et al.
9 Briefly, the
respiratory function of the four simultaneously ex-
posed animals was monitored. The baseline values of
different respiratory parameters collected during the
control period are presented in Table 2. Based on the
baseline values [mean and standard deviation (SD)],
each breath was then classified either as normal or as
indicating sensory irritation, pulmonary irritation,
pulmonary irritation in phase 1, airflow limitation
within the conducting airways of the lungs (i.e.
bronchoconstriction), or their combinations with
each animal acting as its own control.
14 16 Due to
the high number of individual breaths analyzed and
the low coefficients of variation, using four mice per
group is sufficient to establish limits of detection. The
smoothing polynomial spline program
14 was used to
determine changes in each breath variable or cate-
gory, and mean responses of four simultaneously
exposed mice were calculated. This time series
analysis was used to define time /response relation-
ships for each group of mice and each exposure
regimen. The 95% confidence intervals were also
calculated for each smoothed curve.
The animals were observed daily. The body
weights of the animals were also recorded on every
exposure day. Six hours after the final aerosol
exposure, mice were sacrificed with pentobarbital
(Mebunat†), and serum samples as well as tissue
samples from the respiratory tract were collected
from the PBS/glu and Sc/glu mice that were exposed
repeatedly to b-glucan. Serum samples were col-
lected also from the groups PBS and Sc to measure
antibody levels without inhalation exposure. Tissue
samples were collected also from two naı ¨ve/glu mice
6 h after their exposure to 1189 mg/m
3 b-glucan (see
also Table 1).
Measurement of total IgE concentrations and
histopathology of nasal cavity and lungs
The serum total IgE levels were determined with an
enzyme-linked immunosorbent assay as described in
Korpi et al.
9
The mouse skull with nasal cavity and lungs was
collected and fixed with 4% formaldehyde solution.
The mouse skull was decalcified for 6 h in 5% nitric
acid solution (Riedel-de Hae ¨n KG, Seelze, Germany).
After that, multiple sections were cut to reveal the
distribution of epithelial types and submucosal
glands in the nasal cavity (modified after reference
17). The resulting three or four blocks of the tissue
were embedded in paraffin, sectioned at a thickness
of 5 mm, and stained with hematoxylin and eosin
(HE). The left and right lung (all lobes) including
samples from hilar lymph nodes of the lungs were
Respiratory irritation by b-glucan
Mediators of Inflammation Vol 12  2003 141routinely processed, embedded in paraffin, sectioned
at 5 mm, and stained with HE. An experienced
pathologist examined the stained sections of nasal
cavity and lungs with light microscopy.
Statistical analysis
The serum total immunoglobulin E (IgE) levels were
compared between the mouse groups by the Mann /
Whitney U-test (SPSS for MS Windows, release 9.0) to
detect the immunological changes induced by b-
glucan aerosol inhalation. The body weights of the
mice at the first and last exposure day were com-
pared with the Wilcoxon signed Rank Test to detect
changes due to repeated exposures. Differences with
pB/0.05 were considered significant.
Results
Glucan aerosols
During repeated exposures, the number of produced
particles (of diameter from 0.3 to  /10 mm) was
approximately 2 /10
9 particles/m
3 except for the
fifth and the sixth repeated exposure experiments,
when the counts were approximately 7 /10
8 parti-
cles/m
3 due to the change of the nozzle plate. The
diameter of the majority of aerosols produced from
solutions of b-glucan was in the range from 0.3 to 3.0
mm when analyzed in the scale from 0.3 to  /10 mm
with the optical particle counter. The proportion of
particles of 0.5 /3.0 mm and the total number of
generated aerosols became higher when the amount
of b-glucan in the solution was increased (i.e. 425 or
1163 mg/ml). Endotoxin was not detected on any of
the nine analyzed filters (detection limit is 10 pg/ml
13).
Effects of glucan aerosol inhalation on the
murine respiratory pattern
When naı ¨ve/glu mice were exposed to various b-
glucan concentrations, a distinct increase in the time
of braking (TB) was observed (Table 3). However,
the proportion of the sensory irritation (SI) breaths
did not clearly reflect the increase in TB values (Table
3). This is mainly due to the filtering of the data and
the prerequisite of three consecutive breaths in the
same abnormal category. The TB (and SI) response
did not show a clear dependence on b-glucan
concentration, and the respiratory response was of
the same magnitude at the concentration range from
37 to 883 mg/m
3 (Table 3). In the repeated exposures,
Table 2. Respiratory parameters calculated from airﬂow signals
Parameter Abbreviation Definition Unit BALB/cJBom
(n /8) (value9 /SD)
OF1 (n /24)
(value9 /SD)
Tidal volume VT Volume of air inhaled/exhaled
per breath
ml 0.209 /0.02 0.229 /0.03
Respiratory
frequency
F Number of breaths
per minute
BPM 2559 /38 2629 /52
Mid-expiratory flow VD Airflow at 50% VT during
expiration
ml/sec 2.209 /0.43 2.539 /0.45
Time of
inspiration
TI Duration from minimum to
maximum VT
sec 0.099 /0.02 0.099 /0.02
Time of
expiration
TE Duration from maximum to
minimum VT
sec 0.149 /0.03 0.149 /0.02
Time of braking TB Duration of break after
inspiration, prior to expiration
sec 0.029 /0.003 0.029 /0.004
Time of pause TP Duration of pause between
expiration and inspiration
sec 0.029 /0.003 0.039 /0.005
Approximately 3600 breaths were measured for each mouse over a baseline (control) period of 15 min for the average value and SD.
Table 3. Respiratory effects of single b-glucan inhalation exposure on OF1 mice
Concentration of b-glucan
(mg/ml)
Concentration of b-glucan
(mg/m
3)
% of control TB Maximum% of total breaths
classified as SI
0 0 124 B/LOD
61 37 127 12
125 n.a. 137 6
205 252 128 11
425 883 135 B/LOD
1163 1189 150 20
Groups were naı ¨ve/glu, four mice in each exposure. Diagnosis of SI requires an increase in time of breaking (TB) greater than 2.0 times the SD of
the mean baseline value for that mouse. An increase in TB of 20% compared with the value during control period represent the limit of
detection (LOD) in this bioassay, and the LOD of the breath classification for SI 2%
18,19.
n.a., not analyzed.
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Time /response plots of increases in TB and SI
breaths due to exposure to b-glucan are illustrated
in Figs. 1 and 2, respectively. (The 95% confidence
intervals for each smoothed curve are not included in
Figs. 1 and 2 to preserve clarity as they were very
narrow around the smoothed mean curves.) The SI
response started immediately after the onset of the
exposure. During the control periods, no SI was
observed. During the recovery periods of some of the
experiments of repeated exposures, breaths indicat-
ing SI (B/4% of breaths) were detected; however, in
the majority of experiments, no SI during the
recovery period was observed.
Slight pulmonary irritation was noticed occasion-
ally in the repeated exposure experiments at a b-
glucan level of 1189 /53 mg/m
3 (mean9 /SD), as
evidenced by an increase in breaths classified as
Table 4. Respiratory effects of seven b-glucan inhalation exposures on four BALB/cJBom mice
Mouse group Order of repeated exposure % of control period of the respiratory
parameter
Maximum% of total
breaths
classified as:
TB TP SI PI
PBS/glu 1 123 B/LOD 3 B/LOD
2 B/LOD 119 B/LOD B/LOD
3 B/LOD 119 3 B/LOD
4 B/LOD 132 3 11
6 B/LOD 142 4 6
Sc/glu 1 125 B/LOD 5 B/LOD
2 B/LOD 124 B/LOD B/LOD
3 B/LOD B/LOD B/LOD B/LOD
4 B/LOD 120 B/LOD B/LOD
5 B/LOD 125 3 B/LOD
6 B/LOD 130 B/LOD 3
7 121 116 8 3
The dilution of b-glucan solution for the aerosol generator was 125 mg/ml and the mean b-glucan concentration9 /SD was 1189 /53 mg/m
3. The
respiratory parameter data from the fifth and seventh exposures of the group PBS/glu could not be processed due to computer program failure.
Diagnoses of SI or PI require an increase in TB or time of pause (TP), respectively, greater than 2.0 times the SD of the mean baseline value for
that mouse. An increase in TB of 20%, and an increase in TP of 12% compared with the values during control period represent the limit of
detection (LOD) in this bioassay, and the LODs of the breath classifications for SI and PI are 2% for both
18,19.
n.a., not analyzed.
FIG. 1. Average time /response plots of four mice of time of braking (TB) during inhalation exposure to b-glucan aerosol.
Mouse group (immunization/inhalation exposure), the order of exposure, and exposure concentration are indicated. The
naı ¨ve/glu mice were male OF1 mice, and the rest of the groups consisted of female BALB/c mice. The average TB value
calculated from all the breaths collected during the 15 min control period was set equal to 100%, and all the data collected
during the whole experiment (in each 15 sec collection period) was then presented as a percentage of this value. Plots from
the low and high single-exposure concentrations and from repeated exposures experiments are included. During the control
and recovery periods, ﬁltered air was fed into the breathing zone of the animals.
Respiratory irritation by b-glucan
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not observable during the single exposures. When
the maximum SI effect occurred within 3 min after
the onset of the exposure, the maximum PI effect
occurred later (i.e. 6 /20 min after the onset of the
exposure). Slight b-glucan-induced pulmonary irrita-
tion in phase 1 (rapid shallow breathing) (B/12% of
breaths) was observed on few exposure occasions of
the groups Sc/glu and naı ¨ve/glu. b-glucan aerosols
did not cause bronchoconstriction in any of the
experiments.
Serum total IgE levels and tissue samples
Immunization with the fungal extract increased the
serum total IgE levels in mice significantly (p /0.002)
(mean9 /SD, serum total IgE level in the PBS group
was 3739 /123 ng/ml and in the group Sc was
11,8839 /7234 ng/ml). However, no statistically sig-
nificant differences (p  /0.4) in the serum total IgE
levels were caused by seven b-glucan aerosol ex-
posures (group PBS/glu, 3589 /71 ng/ml and group
Sc/glu, 98489 /6305 ng/ml) compared with the mean
serum total IgE levels of the groups PBS and Sc,
respectively.
The bodyweights of the mice did not change
significantly after repeated exposures in either of
the groups PBS/glu or Sc/glu (p /0.1) (data not
shown).
The lung specimens of the seven PBS/glu and
seven Sc/glu mice were normal (i.e. no signs of
inflammation or fibrosis) at histopathological exam-
ination (data not shown). In one PBS/glu and one Sc/
glu mouse, there was a slightly increased number of
perivascular/peribronchial lymphocyte aggregates in
the lungs. The lung specimens of the two heavily-
exposed naı ¨ve/glu mice were normal.
The histopathological analysis of the nasal cavity
did not reveal any signs of inflammation or tissue
damage in any of the Sc/glu mice, the PBS/glu mice,
or either of the two naı ¨ve/glu mice.
Discussion
The primary objective was to study whether b-glucan
aerosols were capable of stimulating the nerve end-
ings directly and whether the response was depen-
dent on previous fungal sensitization. The results
showed that aerosolized form of water-soluble b-
glucan at concentrations from 37 to 1189 mg/m
3
induced a minor SI response, and that the effect
was not affected by preceding fungal exposure. SI
response is not a general response to any type of
inhaled material. For instance, saline solution of
approximately 55 mg/m
3 or ovalbumin solution of
approximately 109 mg/m
3 does not induce the SI
effect.
9 However, inhalation of the fungal (S. char-
FIG. 2. Average time /response plots of breaths indicating sensory irritation (SI) upon inhalation exposure of four mice to b-
glucan aerosol. Mouse group (immunization/inhalation exposure), the order of exposure, and exposure concentration are
indicated. The naı ¨ve/glu mice were male OF1 mice, and the rest of the groups consisted of female BALB/c mice. Diagnosis of
SI requires an increase in time of braking greater than 2.0 times the stabdard deviation of the mean baseline value for that
mouse. The time /response plots were prepared by plotting SI breath classiﬁcation as a percentage of the total number of
breaths collected during each 15 sec period. Unless three or more consecutive breaths were classiﬁed as SI, the program re-
classiﬁed the breath as normal. This was done to reduce the number of abnormal breaths created by body movements
14.
Plots from the low and high single-exposure concentrations and from repeated exposures experiments are included. During
the control and recovery periods, ﬁltered air was fed into the breathing zone of the animals.
A. Korpi et al.
144 Mediators of Inflammation Vol 12  2003tarum) extract showed a distinct SI response. Based
on the b-glucan content of the extract, working
dilutions used, the air volume and the volume of
the working solution aerosolized during an exposure,
we can estimate that the maximum b-glucan con-
centration in the air was 10 mg/m
3 in those experi-
ments.
9 In the present experiments, b-glucan
concentrations from 0 to 1189 mg/m
3 were tested
for their SI potency, and these concentrations were
found to exert lower increases in time of braking and
SI breaths than the S. chartarum extract. Thus, b-
glucan does not contribute significantly to the SI
response provoked by aerosols of fungal extract.
The reason for the fact that the SI response was not
observed at every exposure level or at every occasion
of repeated exposure remains unexplained. The
generated particles reached the murine airways, as
the majority of the particles were*/at each concen-
tration level*/in the range from 0.3 to 3 mm.
20 Since
the biological effect probably depends on the mass
rather than the particle count number, we trans-
formed the results from the optical particle counter
from the count number into mass fraction, assuming
the same density as that of NaCl for all particles. Even
for the 6 /10
9 particles/m
3 generated from the most
concentrated b-glucan solution (1163 mg/ml), the
mass median diameter and geometric SD were low
(2.5 mm and 1.9). This suggests that the particles were
respirable.
21
In indoor environments, microbial growth on
moist building materials has also been related to the
lower respiratory tract symptoms, such as cough,
wheezing and dyspnoea.
22 26 When the amount of b-
glucan was used as an indicator of mold growth in
buildings, increased levels of b-glucan (i.e.  /5 /10
ng/m
3) in the air were reported to be associated with
cough and general symptoms.
27 The ability of b-
glucan to increase the prevalence of cough was also
verified experimentally, when healthy non-sensitive
persons were exposed for 4 h but to much higher
levels of b-glucan (210 ng/m
3) than normally present
in the environment.
7 In the present study, after
repeated exposures to soluble b-glucan only slight
signs of pulmonary irritation were noticed in mice.
Thus, the results from this study suggest that these
sensory and pulmonary irritation responses reported
after inhalation of fungi are probably not attributed to
b-glucan.
Inhalation of aerosols of different mold species for
5 weeks results in a massive cell influx in the lungs of
guinea pigs, akin to the reaction after inhalation of
bacterial endotoxin.
28,29 In this study, repeated in-
halation exposures to b-glucan within 22 days did not
induce notable inflammatory changes in the lungs of
the mice. Histological changes have both been
detected and been absent after acute or chronic
inhalation exposures to b-glucan.
29 34 The reasons
for different observations regarding the degree of cell
infiltration may be due to different glucan delivery
protocols as well as different b-glucan preparations.
It should be noted, however, that any particular form
of b-glucan has not been systematically proven the
most potent when assessing both inflammatory cell
influx
31,34 and other inflammatory markers (e.g.
cytokine and nitric oxide production in in vitro
studies).
11,35 38 Taken together, these results suggest
that the inflammation caused by inhalation of fungi is
not caused by the b-glucan component in the fungal
cell wall.
So far, no evidence of b-glucan being an allergen
by the inhalation route has been presented. This is
supported by the results from this study, since
repeated b-glucan exposure did not increase the
serum total IgE levels in mice, irrespective of whether
the mice were pre-exposed to a fungus. This
corroborates the previous suggestions according to
which b-glucan may act as an adjuvant exerting
additive or synergistic effects only when combined
with other agents, such as allergens (ovalbumin)
either via inhalation exposure or via injection.
39 41
However, various gel-forming b-glucans have differ-
ent effects on balancing helper T-cell activity (i.e. on
the production of Th1 or Th2 antibody subclasses
and cytokines).
42
In conclusion, a single inhalation of b-glucan
(grifolan) aerosol provoked a slight sensory irritation
response in mice without a dose /response relation-
ship at b-glucan levels from 37 to 883 mg/m
3. Mice
repeatedly exposed to an average b-glucan level of
1189 /53 mg/m
3 developed a minor pulmonary irrita-
tion response in addition to sensory irritation. A
previous sensitization to a fungal extract did not
affect the response. No inflammatory changes in the
nasal cavity or in the lungs could be demonstrated
after the exposures. Inhalation of b-glucan did not
increase the production of serum total IgE.
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